Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06979570Not ApplicableTerminated

Personalized Performance Optimization Platform

Role: collaborator

NCT07477028Not Yet Recruiting

Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence

Role: collaborator

NCT06853665Phase 4Recruiting

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

Role: collaborator

NCT07167719Not ApplicableRecruiting

Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges

Role: collaborator

NCT06391697Not ApplicableActive Not Recruiting

Magnetic Bead Tracking System and eOPRA Implant System With Bionic Prosthesis for Transtibial Amputees

Role: collaborator

All 5 trials loaded